Management changes at B&L's vision care unit
This article was originally published in Clinica
Executive Summary
Eye health company Bausch & Lomb has promoted Peter Valenti to corporate vice-president and global president of its vision care business. Mr Valenti, who will assume the new role with effect from July 1, succeeds Stuart Heap, who has chosen to step down for "personal reasons". Mr Heap will continue to be an active strategic advisor to the New York, Rochester-based company. Mr Valenti's current position as B&L Vision Care's president for North America will be filled by Steven Robins. Mr Robins was most recently general manager of Johnson & Johnson's Canadian consumer healthcare division, and vice-president of its consumer group.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.